(Q69910198)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Possible mode of action of 5-aminosalicylic acid (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

B M Peskar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

K W Dreyling

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

B May

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

K Schaarschmidt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H Goebell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 December 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

12 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

51S-56S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2891468%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01312464

6 October 2019

exact match

0 references

cites work

Distribution and metabolism of salicyl-azo-sulfapyridine. II. A study with S35-salicyl-azo-sulfapyridine and S35-sulfapyridine

1 reference

12 December 2020

Clinical Pharmacokinetics of Sulphasalazine

1 reference

12 December 2020

Inhibition of Folate Enzymes by Sulfasalazine

1 reference

12 December 2020

Inhibition by sulfasalazine of LTC synthetase and of rat liver glutathione S-transferases

1 reference

12 December 2020

Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

1 reference

12 December 2020

Effect of 5-aminosalicylic acid (5-ASA) and other salicylates on short-chain fat metabolism in the colonic mucosa. Pharmacological implications for ulcerative colitis

1 reference

12 December 2020

Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients

1 reference

12 December 2020

Inhibition of cytotoxicity by sulfasalazine. II. Sulfasalazine and sulfapyridine inhibit different stages of the NK and NKCF lytic processes

1 reference

12 December 2020

Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid

1 reference

12 December 2020

Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid

1 reference

12 December 2020

Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis

1 reference

12 December 2020

Leukotriene synthesis by human gastrointestinal tissues

1 reference

12 December 2020

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine

1 reference

12 December 2020

Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro

1 reference

12 December 2020

The Influence of Salicyl-azo-Sulfapyridine on the Immune Response to Antigenic Tumour Cells Inoculated into the Coecal Lumen of C3H Mice

1 reference

12 December 2020

Prostaglandins and ulcerative colitis

1 reference

12 December 2020

Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease

1 reference

12 December 2020

Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine)

1 reference

12 December 2020

Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease

1 reference

12 December 2020

The effect of sulfasalazine and its active components on human polymorphonuclear leukocyte function in relation to ulcerative colitis

1 reference

12 December 2020

The role of intestinal bacteria in the metabolism of salicylazosulfapyridine

1 reference

12 December 2020

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

1 reference

12 December 2020

The effect of salazopyrin on water and electrolyte transport in the human colon measured in vivo and in vitro

1 reference

12 December 2020

Distribution studies of salicylazosulfapyridine and its metabolites

1 reference

12 December 2020

Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle

1 reference

12 December 2020

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

12 December 2020

Antifolate actions of sulfasalazine on intact lymphocytes

1 reference

12 December 2020

Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment

1 reference

12 December 2020

5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis?

1 reference

12 December 2020

Inhibition of leucocyte motility by drugs used in ulcerative colitis

1 reference

12 December 2020

Dual effect of sulphasalazine on colonic prostaglandin synthetase

1 reference

12 December 2020

Effect of metronidazole and sulfasalazine on the normal human faecal flora

1 reference

12 December 2020

Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils

1 reference

12 December 2020

Mode of action of sulphasalazine: an alternative view

1 reference

12 December 2020

Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis

1 reference

12 December 2020

Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.

1 reference

12 December 2020

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate

1 reference

12 December 2020

Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils

1 reference

12 December 2020

Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis

1 reference

12 December 2020

Prostaglandins and ulcerative colitis

1 reference

12 December 2020

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

12 December 2020

Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease

1 reference

12 December 2020

Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay

1 reference

12 December 2020

An experiment to determine the active therapeutic moiety of sulphasalazine

1 reference

12 December 2020